Mitigating International Legal Risks Presented in Life Sciences IP Due Diligence Investigations

November 15, 2019 11:15am

Sylvia Georges Evangelinos
Senior Patent Attorney
Novartis Institutes for BioMedical Research (NIBR) (Cambridge, MA)

Janet Xiao
Morrison & Foerster LLP (Palo Alto, CA)

Conducting a baseline international legal risk assessment and finding and utilizing appropriate resources for your IP due diligence examination
  • Identifying potential antitrust and CFIUS risks and adjusting your IP due diligence checklist
  • Tips for the IP due diligence team including identifying wants/needs/must-haves and deal-breakers
  • What to do if legal concerns are uncovered
  • Protecting yourself in the definitive agreements
  • Incorporating lessons from the diligence process to facilitate ultimate integration